We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Andrx Receives New Form 483 After FDA Reinspection
Andrx Receives New Form 483 After FDA Reinspection
April 20, 2006
The FDA has issued Andrx a new Form 483 after a reinspection of the drugmaker’s Florida manufacturing plant, according to documents filed April 19 with the Securities and Exchange Commission (SEC).